Many diseases occur due to mutations in genes, including Mendelian diseases caused by single-gene mutations, and complex genetic diseases caused by the accumulation of mutations in linked or unlinked genomic regions, e.g., cancer and metabolic diseases. With the development of next-generation sequencing (NGS) technologies and the advent of the post-genomic era, scientists can narrow down the genomic regions of interest by target-specific sequencing or obtain information on the entire DNA sequence, including chromosomal and mitochondrial DNA by whole-genome sequencing strategy. However, next-generation sequencing generates large amounts of data, even targeted sequencing (>1Mb). Therefore, extensive and time-consuming bioinformatics analysis is required, limiting project progress and disease study progression.
CD Genomics offers customized bioinformatics solutions for NGS data to streamline your research. We facilitate the identification of genetic variant loci related to genetic diseases, tumors, metabolic disorders, etc., and promote the integration of disease genesis research and translational medicine.
Our NGS and bioinformatics analysis platforms combine affordable cost, optimized data processing capabilities, enhanced computational power, and many other advantages to provide customized analysis services, including but not limited to:
CD Genomics provides accurate and cost-effective bioinformatics analysis services. Our professional expert team executes quality management, following every procedure to ensure confident and unbiased results.
If you have additional requirements or questions, please feel free to contact us.
References:
